Press review (December 10, 2011) – Revue de presse (10 décembre 2011)

Two Drugs Offer New Hope for Breast Cancer Patients

It's not often that researchers get to report good news for cancer patients, but this week at the San Antonio Breast Cancer Symposium, researchers announced encouraging results from studies of two cancer medications (pertuzumab and everolimus) that appeared to keep women's disease from advancing.

By Alice Park. TIME

http://healthland.time.com/2011/12/08/two-drugs-offer-new-hope-for-breast-cancer-patients/

Stanford, UCSF to test ultrasound for cancer pain

Scientists at Stanford and UCSF are recruiting patients for two clinical trials to test the use of ultrasound waves, as an alternative to traditional radiation therapy, to ease pain in people whose cancer has spread to their bones.

By  Erin Allday. In San Francisco Chronicle

http://www.sfgate.com/cgi-bin/article.cgi?f=/c/a/2011/12/04/BATE1M79J2.DTL

Ex-chief of Japan nuclear plant has cancer

The former chief of Japan's crippled nuclear plant, who left the job last week, has cancer of the esophagus, TEPCO said Friday, adding it was unlikely to be linked to radiation exposure.

AFP

http://www.google.com/hostednews/afp/article/ALeqM5iX10KfPyCTZukARxlGJOegZLp8kg?docId=CNG.33ba93cd99323b241fb70a8bcd7637cf.5f1

40% Of Cancers Attributed To Preventable Factors

More than 100,000 cancers - nearly 4 in 10 of all those diagnosed in Britain each year - could be prevented if people made different choices, according to a new study by Cancer Research UK.

In Huffington Post

http://www.huffingtonpost.com/2011/12/07/40-of-cancers-attributed-_n_1135015.html

Active Surveillance May Benefit Men With Low-Risk Prostate Cancer

But report says more needs to be known about the long-term outcome of this approach.

By Steven Reinberg. In U.S. News & World Report

http://health.usnews.com/health-news/family-health/cancer/articles/2011/12/07/active-surveillance-may-benefit-men-with-low-risk-prostate-cancer

Should Nuns Take the Pill for Health Reasons?‎

The world’s 94,790 nuns pay a price for their chastity: an increased risk of breast, ovarian and uterine cancers.

By Katie Moisse. ABC News (blog)

http://abcnews.go.com/blogs/health/2011/12/08/should-nuns-take-the-pill-for-health-reasons/

EUROECHO: Cancer Drug Has Early Cardiac Effects

Breast cancer patients often develop early signs of cardiotoxicity within months of starting treatment with trastuzumab (Herceptin), according to a small study with implications for heart failure prevention.

By Crystal Phend. MedPage Today

http://www.medpagetoday.com/MeetingCoverage/EUROECHO/30100?pfc=101&spc=230

FDA panel backs Pfizer's drug for kidney cancer (axitinib - Inlyta)

Pfizer Inc won unanimous expert backing for its Inlyta experimental drug for patients with advanced kidney cancer.

By Anna Yukhananov. In Reuters

http://www.reuters.com/article/2011/12/07/us-fda-pfizer-inlyta-idUSTRE7B625720111207

Cancer : pas de périostine, plus de métastase !

Des scientifiques suisses affirment avoir trouvé un élément clé toujours impliqué dans l'établissement des métastases : la périostine. Après l'inhibition de cette protéine de la matrice extracellulaire chez des souris, les cellules cancéreuses n’ont jamais pu coloniser un nouvel organe. Une nouvelle piste à explorer au plus vite !

Par Janlou Chaput. Dans Futura Sciences

http://www.futura-sciences.com/fr/news/t/medecine/d/cancer-pas-de-periostine-plus-de-metastase_35166/

Cancer: Génopharm bientôt suspendu

Le laboratoire français Genopharm, accusé d'avoir commercialisé des lots périmés d'un anticancéreux, le Thiotepa, va recevoir "sous peu" la lettre qui suspend son autorisation d'exercer en France, a indiqué aujourd'hui l'agence du médicament (Afssaps).

Dans Le Figaro.

http://www.lefigaro.fr/flash-actu/2011/12/08/97001-20111208FILWWW00768-cancer-genopharm-bientot-suspendu.php

La maternité protège du cancer

À défaut d'enfants, des chercheurs australiens proposent… la pilule!

Par Damien Mascret. Dans Le Figaro

http://www.lefigaro.fr/sciences/2011/12/07/01008-20111207ARTFIG00831-la-maternite-protege-du-cancer.php

Cancer du sein : la survie des femmes accrue par une combinaison de deux molécules‎

Selon une récente étude américaine, la prise combinée de deux molécules particulières augmenterait la survie des femmes atteintes du cancer du sein le plus fréquent.

Dans Maxi-Sciences

http://www.maxisciences.com/cancer-du-sein/cancer-du-sein-la-survie-des-femmes-accrue-par-une-combinaison-de-deux-molecules_art19416.html

Santé: Cas de cancer du poumon en Algérie‎

Traitement cancer du poumon - 3 500 cas de cancer du poumon diagnostiqués chaque année. Le cancer du poumon est la cause la plus fréquente des décès dus au cancer chez les hommes et les femmes à travers le monde. L'Algérie n'échappe pas à ce fléau ravageur.

Par Amel Bouakba. Dans Afrique en Ligne

http://www.afriquejet.com/traitement-cancer-poumon-2011120729093.html